Kwasi Osae-Kwapong

Title: Kwasi Osae-Kwapong: Innovator in Human Insulin-Like Growth Factor Research

Introduction

Kwasi Osae-Kwapong is a notable inventor based in White Plains, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of human insulin-like growth factor binding proteins. His work has implications for various medical applications, including growth disorders and metabolic diseases.

Latest Patents

Kwasi Osae-Kwapong holds a patent for a non-recombinant human insulin-like growth factor binding protein concentrate. This patent describes a human insulin-like growth factor (IGF) binding protein stock solution and the method of making it. The solution includes a non-recombinant human IGF binding protein-3 (nr-IGFBP-3) in an aqueous buffered medium. The concentration of the nr-IGFBP-3 in the stock solution ranges from about 16 micrograms per milliliter (μg/ml) to about 40 μg/ml. Additionally, a kit is included that features a set of calibrators for nr-IGFBP-3, which contains the protein in different concentrations.

Career Highlights

Kwasi Osae-Kwapong is currently employed at Siemens Healthcare Diagnostics GmbH, where he continues to advance his research and development efforts. His work at Siemens has allowed him to collaborate with other experts in the field and contribute to innovative healthcare solutions.

Collaborations

Some of his coworkers include Michele Smith and Ryan Spears, who work alongside him in various projects related to his research.

Conclusion

Kwasi Osae-Kwapong is a distinguished inventor whose work in human insulin-like growth factor binding proteins has the potential to impact medical science significantly. His contributions to biotechnology exemplify the importance of innovation in healthcare.